Efficacy And Safety Of Denosumab Vs. Risedronate In Postmenopausal Women Suboptimally Adherent To Alendronate: Results From A Randomized Open-Label Study
AuthID
P-006-K3D
P-006-K3D
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service